The application of two different blood cell separators to harvest CD34+ cells in patients suffering from non Hodgkin's lymphoma

International Journal of Artificial Organs

Volumn 22, Issue 8, 1999, Pages 583-588

  Serafini, R ^a   Menichella, G ^a   Ciarli, M ^a   Pierelli, L ^a   Lai, M ^a   Paladini, U ^a   Cicconi, S ^a   Sica, S ^a   Ortu La Barbera, E ^a   Laurenti, L ^a   Leone, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Blood cell separators efficiency; CD34+ cell harvest; Non Hodgkin's lymphoma; Peripheral blood stem cell

Indexed keywords

BLOOD; CYTOLOGY; ONCOLOGY; SEPARATORS;

BLOOD CELL SEPARATOR EFFICIENCY; BLOOD CELL SEPARATORS; CD34+ CELL HARVEST; CD34+ CELLS; EXCEL; GROWTH FACTOR; NON-HODGKIN LYMPHOMA; PATIENT'S SUFFERING; PERIPHERAL BLOOD; PERIPHERAL BLOOD STEM CELLS;

STEM CELLS;

CARBOPLATIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; METHYLPREDNISOLONE; MITOXANTRONE; RECOMBINANT GROWTH FACTOR;

ADULT; APHERESIS; ARTICLE; BLOOD CELL COUNT; CANCER COMBINATION CHEMOTHERAPY; CELL SEPARATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKAPHERESIS; MALE; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; T LYMPHOCYTE SUBPOPULATION;

EID: 0032705363     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889902200809     Document Type: Article

References (19)

1. Gillespie TW, Hillyer CD. Peripheral blood progenitor cells for marrow reconstitution: mobilization and collection strategies. Transfusion 1996; 36: 611-21.
2. Valbonesi M. Hemopoietic stem cells: technical and methodological considerations. Stem cells 1993; 11 (suppl. 3): S58-63.
3. Mitterer M, Hirber J, Gentilini I, et al. Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemoterapy and rh-G-CSF. Bone Marrow Transplant 1996; 18: 611-7.
4. Stroncek DF, Clay ME Smith J, Jaszcz WB, Herr G, McCullough J. Comparison of two blood cell separators in collecting peripheral blood stem cell components. Transfus Med 1997; 7 (2): 95-9.
5. Morton JAP, Baker DP, Hutchins CJ, Durrant STS. The COBE Spectra cell separator is more effective than the Haemonetics MCS-3P cell separator for peripheral blood progenitor cell harvest after mobilization with cyclophpsphamide and filgrastim. Transfusion 1997; 37: 631-33.
6. Jestice HK, Boracks P, Scott MA, Bloxham D, Price J, Marcus RE. Improved yield of peripheral blood progenitor cells on the Cobe Spectra. Bone Marrow Transplant 1996; 18: 597-601.
7. Mehta J, Powles R, Treleaven J, et al. Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3p cell separators for leukapheresis after high-dose Filgrastim in patients with Heamatologic Malignancies. J Clin Apheresis 1997; 12: 63-7.
8. Dzieczkowski JS, McGonical M, Cook J, Sugrue M, Andersen J, Anderson KC. A comparison of peripheral blood stem cell apheresis using the Fenwal CS3000 Plus and COBE. Spectra. Transfus Sci 1995; 16: 71-77.
9. Bambi F, Faulkner LB, Azzari C, et al. Pediatric peripheral blood progenitor cell collection: Haemonetics MCS 3P versus COBE Spectra versus Fresenius AS104. Transfusion 1998; 38: 70-4.
10. James P. Collection of peripheral blood stem cells on Spectra. J Clin Apheresis 1994; 9: 33-4.
11. Menichella G, Lai M, Pierelli L, et al. Evaluation of two different protocols for peripheral blood stem cell collection with the Fresenius AS 104 blood cell separator. Vox Sang 1997; 73: 230-6.
12. Menichella G, Lai M, Pierelli L, et al. Evaluation of new protocol for peripheral blood stem cell collection with the Fresenius AS 104 cell separator. J Clin Apheresis 1997; 12 (2): 82-6.
13. Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1997; 20: 587-91.
14. Demirer T, Buckner CD, Gooley T et al. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 1996; 17: 937-41.
15. Schwella N, Beyer J, Schwaner I, et al. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol 1996; 14(4): 1114-21.
16. Olivieri A, Offidani M, Ciniero L, et al. Optimization of the yeld of PBSC for autotransplantation mobilized by high-dose chemotherapy and rhG-CSF: proposal for a mathematical model. Bone Marrow Transplant 1994; 14: 273-8.
17. Schots R, Van Riet I, Damiaens S, et al. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996; 17: 509-15.
18. Keung YK, Cobos E, Dunn D, et al. Determining factors for the outcome of peripheral blood progenitor cells harvests. J Clin Apheresis 1996; 11: 23-26.
19. Mohle R, Murea S, Pforsich M, Witt B, Haas R. Estimation of the progenitor cell yeld in a leukapheresis product by previous measurement of CD34+ cells in the peripheral blood. Vox Sang 1996; 71: 90-6.